The collaboration way..., page-8

One thing to consider.....

Merck (by whatever name), Pfizer, GSK, Novartis are all well known

companies with extensive ties to the US market.....As such biotech

investors are familiar with them and their successes....That Immutep

can be associated with them is a very positive position....That

association appears to be becoming stronger by the month.....

The ability to initiate sponsored trials should not be underestimated

either.....Krankenhaus have upped the ante as well, they must have

seen something that convinced them to take a step further.....

What will tonight bring?....I'll leave that to others but I'll be watching

with interest....